AHMEDABAD, India and NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it ...

Zydus Lifesciences Limited announced on March 11, 2025, that it entered into an agreement to acquire a majority stake in Amplitude Surgical. Reports state that Zydus Lifesciences has a tender offer ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has triggered the first $20 million contingent payment under its previously disclosed strategic ...

Zydus Lifesciences has entered into a licensing agreement with Dr Reddy’s Laboratories to co-market in India the Pertuzumab biosimilar, a critical treatment for HER2 positive breast cancer, per a CNBC ...

AHMEDABAD, India, Jan. 7, 2025 /PRNewswire/ -- Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as 'Zydus'), a global innovation ...

The MarketWatch News Department was not involved in the creation of this content. AHMEDABAD, India and PLANEGG-MARTINSRIED, Germany, Dec. 9, 2025 /CNW/ -- Zydus Lifesciences Limited (including its ...

BENGALURU, Aug 11 (Reuters) - Indian generic drugmaker Zydus Lifesciences Ltd (ZYDU.NS), opens new tab said on Friday its profit more than doubled in the first quarter, driven by strong sales in its U ...

Zydus Lifesciences said it has received final approval from the United States Food and Drug Administration (USFDA) for Ivermectin Tablets USP, 3 mg, and Dapsone Tablets USP, 25 mg and 100 mg.

Zydus Lifesciences on Thursday said the US health regulator has granted Orphan Drug Designation (ODD) to Desidustat, a novel product for the treatment of beta-thalassemia. The US Food and Drug ...

BENGALURU, May 18 (Reuters) - India's Zydus Lifesciences Ltd (ZYDU.NS), opens new tab reported its smallest profit in 14 quarters, hurt by a goodwill impairment charge and costs related to shutting ...

Shares of Zydus Lifesciences shares rose in the opening trade on February 19 after the company received final approval from the United States Food and Drug Administration (USFDA) for Bosentan tablets ...

Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical, France, at a price of €6.25 per Amplitude Surgical share. Purchase consideration amounts to ...